Our study identified and validated a 6-SLC gene (SLC39A8, SLC2A3, SLC39A13, SLC35B1, SLC4A3, SLC12A2) signature that could predict prognosis of CRC patients. This evidence concerns the gene CCL21 and colorectal carcinoma.